日本語View as Markdown

Sirtuin Type 1 Mediates the Retinal Protective Effect of Hydrogen-Rich Saline Against Light-Induced Damage in Rats.

水素富化生理食塩水による光誘発性網膜障害保護におけるSirtuin 1の媒介機序

animal study injection / infusion positive

Abstract

In a rat model of intense light-induced retinal injury, intraperitoneal administration of hydrogen-rich saline (HRS) for 5 days elevated Sirt1 (Sirtuin Type 1) expression, partially preserved electroretinogram a- and b-wave amplitudes, and reduced outer nuclear layer cell loss. The Sirt1 activator resveratrol reproduced these protective outcomes, while the Sirt1 inhibitor EX-527 and Sirt1-targeting siRNAs each abolished the benefits of HRS, confirming Sirt1 as a necessary mediator. HRS also upregulated Bcl-2 protein and superoxide dismutase activity, and in a Sirt1-dependent fashion reduced Bax expression, cleaved caspase-3 levels, and the lipid peroxidation marker malondialdehyde. Collectively, these findings indicate that HRS confers retinal protection against phototoxic injury primarily through Sirt1-mediated suppression of apoptosis and oxidative stress.

Mechanism

HRS upregulates Sirt1, which in turn promotes Bcl-2 expression, suppresses Bax and cleaved caspase-3 to inhibit apoptosis, and enhances SOD activity while reducing malondialdehyde, collectively protecting retinal cells from phototoxic oxidative damage.

Bibliographic

Authors
Qi LS, Yao L, Liu W, Duan WX, Wang B, Zhang LL, et al.
Journal
Invest Ophthalmol Vis Sci
Year
2015
PMID
26720481
DOI
10.1167/iovs.15-17034

Tags

Disease:網膜疾患 Mechanism:抗酸化酵素 アポトーシス抑制 脂質過酸化 ミトコンドリア 酸化ストレス 活性酸素種

Delivery context

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

Safety notes

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 26720481. https://h2-papers.org/en/papers/26720481
Source: PubMed PMID 26720481